Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  adenosine A3 receptor agonist CF102
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CF102-201HCC, NCI-2016-00211, NCT02128958
Start Over